Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Dyscrasia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05271526
What this trial is testing

Real World Evidence of Benralizumab in Eosinophilic Severe AsThma in Russia (BEST)

Who this might be right for
Severe Eosinophilic Asthma
AstraZeneca 3
Testing effectiveness (Phase 2)UnknownNCT05951855
What this trial is testing

Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients

Who this might be right for
Acute Myeloid Leukemia (Relapsed/Refractory)
The First Affiliated Hospital of Soochow University 42
Not applicableStudy completedNCT04679285
What this trial is testing

Minimal Residual Disease Evaluation on Cryopreserved Ovarian Fragments in Younger Patients Treated for Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
University Hospital, Lille 9
Not applicableNo Longer AvailableNCT01196208
What this trial is testing

A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001

Who this might be right for
Disease, HodgkinLymphoma, Large-Cell, AnaplasticLymphoma, Non-Hodgkin+1 more
Seagen Inc.
Not applicableUnknownNCT02782338
What this trial is testing

The Effect of Voltaren-ophtha 0.1% Eye Drops on INR Levels (International Normalized Ratio) in Patients Taking Warfarin

Who this might be right for
Blood Coagulation Disorders
Wolfson Medical Center 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT06742138
What this trial is testing

To Evaluate the Efficacy and Safety of QL2109 and DARZALEX FASPRO® in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Qilu Pharmaceutical Co., Ltd. 284
Not applicableLooking for participantsNCT00230685
What this trial is testing

Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia

Who this might be right for
Telangiectasia, Hereditary Hemorrhagic
Imperial College London 2,000
Testing effectiveness (Phase 2)UnknownNCT00408447
What this trial is testing

Stem Cell Transplant in Sickle Cell Disease and Thalassemia

Who this might be right for
Sickle Cell DiseaseBeta Thalassemia
Columbia University 53
Not applicableStudy completedNCT04873349
What this trial is testing

Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients

Who this might be right for
Covid19COVID-19 Respiratory InfectionSymptoms and Signs+2 more
Shimaa M. Abdelgawad 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04023526
What this trial is testing

Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy

Who this might be right for
Leukemia, Myeloid, Acute
OncoVerity, Inc. 103
Not applicableStudy completedNCT01805843
What this trial is testing

Pulmonary Vasculopathy Under Second-line Therapy of Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Medical University of Graz 16
Early research (Phase 1)Ended earlyNCT00100152
What this trial is testing

A Notch Signalling Pathway Inhibitor for Patients With T-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)(0752-013)

Who this might be right for
Leukemia, Lymphoblastic, Acute, T-cellMyelogenous LeukemiaChronic Lymphocytic Leukemia+1 more
Merck Sharp & Dohme LLC 50
Not applicableStudy completedNCT01906515
What this trial is testing

Impact of SpHb Monitoring on Transfusion

Who this might be right for
Anemia
Cairo University 106
Large-scale testing (Phase 3)Study completedNCT00928486
What this trial is testing

A Safety Confirmation Study on Lenalidomide With Dexamethasone In Japanese Patients With Previously Treated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 25
Testing effectiveness (Phase 2)Study completedNCT02598583
What this trial is testing

Dose-Escalation Study of ALXN1210 IV in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Who this might be right for
PNH
Alexion Pharmaceuticals, Inc. 13
Large-scale testing (Phase 3)UnknownNCT03942094
What this trial is testing

Nilotinib for First-line Newly Diagnosed CML-CP Patients

Who this might be right for
Chronic Myeloid Leukemia, Chronic PhaseNilotinib
Shenzhen Second People's Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00056966
What this trial is testing

Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases

Who this might be right for
Hematologic Malignancy
Baylor College of Medicine 24
Testing effectiveness (Phase 2)Ended earlyNCT02152956
What this trial is testing

Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)

Who this might be right for
AML
MacroGenics 244
Not applicableEnded earlyNCT04208451
What this trial is testing

The Effects of One Month Consumption of Standardized Aronia Melanocarpa Extract on Anemia in Patients on Hemodialysis

Who this might be right for
Renal DiseaseDialysis; ComplicationsAnemia
University of Kragujevac 30
Not applicableApproved For MarketingNCT05463939
What this trial is testing

Teclistamab Expanded Access Treatment Protocol for Relapsed or Refractory Multiple Myeloma Patients

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Janssen Research & Development, LLC
Next Page